Craig N. Karson

4.9k total citations · 1 hit paper
83 papers, 3.9k citations indexed

About

Craig N. Karson is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Craig N. Karson has authored 83 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 21 papers in Cognitive Neuroscience and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Craig N. Karson's work include Schizophrenia research and treatment (35 papers), Functional Brain Connectivity Studies (12 papers) and Advanced MRI Techniques and Applications (10 papers). Craig N. Karson is often cited by papers focused on Schizophrenia research and treatment (35 papers), Functional Brain Connectivity Studies (12 papers) and Advanced MRI Techniques and Applications (10 papers). Craig N. Karson collaborates with scholars based in United States, Denmark and Japan. Craig N. Karson's co-authors include Richard A. Komoroski, Robert E. Mrak, Llewellyn B. Bigelow, W. Sue T. Griffin, D A Cardwell, Joel E. Kleinman, Daniel R. Weinberger, Richard Jed Wyatt, Peter A. LeWitt and Edgar García‐Rill and has published in prestigious journals such as American Journal of Psychiatry, Brain and Neurology.

In The Last Decade

Craig N. Karson

81 papers receiving 3.8k citations

Hit Papers

SPONTANEOUS EYE-BLINK RATES AND DOPAMINERGIC SYSTEMS 1983 2026 1997 2011 1983 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig N. Karson United States 37 1.3k 1.2k 945 638 500 83 3.9k
Steven Matthysse United States 33 1.4k 1.0× 1.2k 1.0× 625 0.7× 597 0.9× 418 0.8× 92 3.5k
Jody Tanabe United States 40 1.8k 1.3× 753 0.6× 1.1k 1.1× 840 1.3× 362 0.7× 95 5.0k
Paul Fedio United States 36 2.7k 2.0× 2.0k 1.7× 685 0.7× 351 0.6× 390 0.8× 72 5.1k
Zoltán Janka Hungary 34 1.2k 0.9× 847 0.7× 660 0.7× 796 1.2× 445 0.9× 173 4.1k
Alan J. Zametkin United States 32 2.1k 1.5× 2.8k 2.3× 798 0.8× 350 0.5× 874 1.7× 64 4.7k
Olivier Blin France 38 1.2k 0.9× 1.2k 1.0× 1.0k 1.1× 504 0.8× 455 0.9× 170 4.9k
Llewellyn B. Bigelow United States 34 1.3k 0.9× 1.7k 1.4× 806 0.9× 564 0.9× 392 0.8× 80 3.7k
María A. Ron United Kingdom 46 1.7k 1.3× 2.4k 2.0× 546 0.6× 350 0.5× 496 1.0× 120 6.0k
Janice R. Stevens United States 29 1.2k 0.9× 1.5k 1.2× 1.2k 1.3× 424 0.7× 267 0.5× 76 3.3k
Richard Perry United Kingdom 28 2.5k 1.9× 2.2k 1.9× 625 0.7× 672 1.1× 141 0.3× 70 5.1k

Countries citing papers authored by Craig N. Karson

Since Specialization
Citations

This map shows the geographic impact of Craig N. Karson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig N. Karson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig N. Karson more than expected).

Fields of papers citing papers by Craig N. Karson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig N. Karson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig N. Karson. The network helps show where Craig N. Karson may publish in the future.

Co-authorship network of co-authors of Craig N. Karson

This figure shows the co-authorship network connecting the top 25 collaborators of Craig N. Karson. A scholar is included among the top collaborators of Craig N. Karson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig N. Karson. Craig N. Karson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kamat, Siddhesh, Blanca Gutiérrez, Anna Eramo, et al.. (2013). Initial assessment of real-world usage of extended-release injectable paliperidone palmitate among medicaid insured schizophrenia patients. Value in Health. 16(3). A61–A61. 1 indexed citations
3.
Komoroski, Richard A., John M. Pearce, W. Sue T. Griffin, et al.. (2001). Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study. Psychiatry Research Neuroimaging. 106(3). 171–180. 13 indexed citations
4.
Lindquist, Diana M., et al.. (2000). Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo. Magnetic Resonance in Medicine. 43(3). 355–358. 27 indexed citations
6.
Skinner, R.D., et al.. (1999). Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder. Depression and Anxiety. 9(3). 122–130. 68 indexed citations
7.
Omori, Masao, John Pearce, Richard A. Komoroski, et al.. (1997). In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia. Biological Psychiatry. 42(5). 359–366. 41 indexed citations
8.
Komoroski, Richard A., et al.. (1994). In vivo19F spin relaxation and localized spectroscopy of fluoxetine in human brain. Magnetic Resonance in Medicine. 31(2). 204–211. 51 indexed citations
9.
Komoroski, Richard A., et al.. (1993). In vivo 7Li nuclear magnetic resonance study of lithium pharmacokinetics and chemical shift imaging in psychiatric patients. Psychiatry Research Neuroimaging. 50(2). 67–76. 29 indexed citations
10.
Karson, Craig N., et al.. (1992). Fluoxetine and trifluoperazine in human brain: A 19F-nuclear magnetic resonance spectroscopy study. Psychiatry Research Neuroimaging. 45(2). 95–104. 34 indexed citations
11.
Karson, Craig N. & T. Michael Kashner. (1991). Assault Increases the Cost of Care among Inpatient Veterans with Schizophrenia. The Journal of Nervous and Mental Disease. 179(11). 702–703. 6 indexed citations
12.
Komoroski, Richard A., et al.. (1991). Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy. Biological Psychiatry. 29(7). 711–714. 29 indexed citations
13.
Karson, Craig N., Edgar García‐Rill, JoAnn Biedermann, et al.. (1991). The brain stem reticular formation in schizophrenia. Psychiatry Research Neuroimaging. 40(1). 31–48. 90 indexed citations
14.
Karson, Craig N., R. A. Dykman, & Stephen R. Paige. (1990). Blink Rates in Schizophrenia. Schizophrenia Bulletin. 16(2). 345–354. 72 indexed citations
15.
Myslobodsky, M., Richard Coppola, J. Bar‐Ziv, et al.. (1989). EEG asymmetries may be affected by cranial and Brain parenchymal asymmetries. Brain Topography. 1(4). 221–228. 32 indexed citations
16.
Karson, Craig N., Richard Coppola, D.G. Daniel, & Daniel R. Weinberger. (1988). Computerized EEG in Schizophrenia. Schizophrenia Bulletin. 14(2). 193–197. 57 indexed citations
17.
Karson, Craig N., Terry E. Goldberg, & Richard Coppola. (1988). Preliminary studies of alpha rhythm and neuropsychological impairment in schizophrenia. Schizophrenia Research. 1(6). 399–403. 6 indexed citations
18.
Goldberg, Terry E., et al.. (1988). Intellectual impairment in adolescent psychosis. Schizophrenia Research. 1(4). 261–266. 36 indexed citations
19.
Jaffe, M. J., et al.. (1987). Ganzfeld electroretinographic findings in parkinsonism: untreated patients and the effect of levodopa intravenous infusion.. Journal of Neurology Neurosurgery & Psychiatry. 50(7). 847–852. 58 indexed citations
20.
Jaffe, M. J., et al.. (1987). The effect of metoclopramide on the ganzfeld electroretinogram. Vision Research. 27(10). 1693–1700. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026